These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 2073770)
1. Modification of serum and membrane lipid composition induced by diet in patients with chronic renal failure. Loschiavo C; Ferrari S; Aprili F; Grigolini L; Faccini G; Maschio G Clin Nephrol; 1990 Dec; 34(6):267-71. PubMed ID: 2073770 [TBL] [Abstract][Full Text] [Related]
2. Lipoproteins and lipid peroxidation abnormalities in patients with chronic renal disease. Ong-Ajyooth L; Ong-Ajyooth S; Sirisalee K; Nilwarangkur S J Med Assoc Thai; 1996 Aug; 79(8):505-12. PubMed ID: 8855633 [TBL] [Abstract][Full Text] [Related]
3. Effect of protein-restricted diet on serum lipids and atherosclerosis risk factors in patients with chronic renal failure. Loschiavo C; Ferrari S; Panebianco R; Bedogna V; Oldrizzi L; Bonazzi L; Maschio G Clin Nephrol; 1988 Mar; 29(3):113-8. PubMed ID: 3359702 [TBL] [Abstract][Full Text] [Related]
4. Dyslipidemia in patients with chronic renal failure and in renal transplant patients. Shah B; Nair S; Sirsat RA; Ashavaid TF; Nair KG J Postgrad Med; 1994; 40(2):57-60. PubMed ID: 8737552 [TBL] [Abstract][Full Text] [Related]
5. Physicochemical modifications induced by statins therapy on human erythrocytes membranes. Broncel M; Bała A; Koter-Michalak M; Duchnowicz P; Wojsznis W; Chojnowska-Jezierska J Wiad Lek; 2007; 60(7-8):321-8. PubMed ID: 18175550 [TBL] [Abstract][Full Text] [Related]
6. Serum lipids in patients with chronic renal failure on long-term, protein-restricted diets. Maschio G; Oldrizzi L; Rugiu C; Loschiavo C Am J Med; 1989 Nov; 87(5N):51N-54N. PubMed ID: 2486548 [TBL] [Abstract][Full Text] [Related]
7. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study. Svensson M; Schmidt EB; Jørgensen KA; Christensen JH Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564 [TBL] [Abstract][Full Text] [Related]
8. Lipids and apolipoproteins change during the progression of chronic renal failure. Bergesio F; Monzani G; Ciuti R; Serruto A; Benucci A; Frizzi V; Salvadori M Clin Nephrol; 1992 Nov; 38(5):264-70. PubMed ID: 1451339 [TBL] [Abstract][Full Text] [Related]
9. Effect of dietary manipulation on the lipid abnormalities in patients with chronic renal failure. Maschio G; Oldrizzi L; Rugiu C; De Biase V; Loschiavo C Kidney Int Suppl; 1991 Apr; 31():S70-2. PubMed ID: 2046274 [TBL] [Abstract][Full Text] [Related]
10. Lecithin: cholesterol acyltransfer, dyslipoproteinaemia and membrane lipids in uraemia. Gillett MP; Obineche EN; El-Rokhaimi M; Lakhani MS; Abdulle A; Sulaiman M J Nephrol; 2001; 14(6):472-80. PubMed ID: 11783603 [TBL] [Abstract][Full Text] [Related]
11. [Antibodies against heat shock proteins (HSP) in children with chronic renal failure (CRF)--preliminary results]. Musiał K; Zwolińska D; Polak-Jonkisz D; Makulska I; Miler M Przegl Lek; 2006; 63 Suppl 3():60-2. PubMed ID: 16898490 [TBL] [Abstract][Full Text] [Related]
12. [Effect of lipid lowering diet on serum lipids in peritoneal dialysis patients]. Jedrzejowski A; Lis D; Majcher A; Ziółkowska H; Roszkowska-Blaim M; Wajda M; Sieniawska M Pol Merkur Lekarski; 2000 Apr; 8(46):266-7. PubMed ID: 10897643 [TBL] [Abstract][Full Text] [Related]
14. Metabolic effects of keto acid--amino acid supplementation in patients with chronic renal insufficiency receiving a low-protein diet and recombinant human erythropoietin--a randomized controlled trial. Teplan V; Schück O; Votruba M; Poledne R; Kazdová L; Skibová J; Malý J Wien Klin Wochenschr; 2001 Sep; 113(17-18):661-9. PubMed ID: 11603100 [TBL] [Abstract][Full Text] [Related]
15. Diets rich in saturated and polyunsaturated fatty acids: metabolic shifting and cardiac health. Diniz YS; Cicogna AC; Padovani CR; Santana LS; Faine LA; Novelli EL Nutrition; 2004 Feb; 20(2):230-4. PubMed ID: 14962692 [TBL] [Abstract][Full Text] [Related]
16. [Disordered lipid metabolism and the morphofunctional instability of the erythrocyte membranes in patients with terminal kidney failure]. Grinshteĭn IuI; Tereshchenko VP; Tereshchenko IuA; Romanova VIa Ter Arkh; 1990; 62(6):84-8. PubMed ID: 2218935 [TBL] [Abstract][Full Text] [Related]
17. Effects of soybean D-LeciVita product on serum lipids and fatty acid composition in type 2 diabetic patients with hyperlipidemia. Ristić Medić D; Ristić V; Arsić A; Postić M; Ristić G; Blazencić Mladenović V; Tepsić J Nutr Metab Cardiovasc Dis; 2006 Sep; 16(6):395-404. PubMed ID: 16935698 [TBL] [Abstract][Full Text] [Related]
18. [Lipoprotein (a) in children with chronic renal failure treated conservatively]. Zwolińska D; Kiliś-Pstrusińska K; Szprynger K Pol Merkur Lekarski; 1997 Sep; 3(15):126-8. PubMed ID: 9461709 [TBL] [Abstract][Full Text] [Related]
19. Serum lipid concentrations correlate with the progression of chronic renal failure. Yang WQ; Song NG; Ying SS; Liang HQ; Zhang YJ; Wei MJ; Wu KF Clin Lab Sci; 1999; 12(2):104-8. PubMed ID: 10387487 [TBL] [Abstract][Full Text] [Related]
20. The effect of n-3 fatty acids on C-reactive protein levels in patients with chronic renal failure. Madsen T; Schmidt EB; Christensen JH J Ren Nutr; 2007 Jul; 17(4):258-63. PubMed ID: 17586424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]